An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by lysis, they release new infectious virus particles to help destroy the remaining tumour.
Join our social circle:
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration with Myeloma UK and Celgene Using REOLYSIN® in Combination with Imnovid® or Revlimid® in Patients with Myeloma Read More
Oncolytics Biotech® Inc. Announces 2016 Year-End Results Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
Oncolytics Biotech® Inc. Enters into First-in-Class Collaboration w Myeloma UK and Celgene Using REOLYSIN® [cont'd] https://t.co/jNgmG6UZP6
Oncolytics Biotech® Inc. Collaborators Present Initial Results from REO 019 Study..[cont'd] https://t.co/dFjpBUiufH